Lin Elizabeth Yeu 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Nov 6, 2024
Insider Transaction Report
Form 4
Lin Elizabeth Yeu
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-11-04+41,074→ 41,074 totalExercise: $46.21Exp: 2034-11-03→ Common Stock (41,074 underlying) - Award
Restricted Stock Units
2024-11-04+27,278→ 27,278 total→ Common Stock (27,278 underlying)
Footnotes (3)
- [F1]Option granted in connection with the Reporting Person's appointment as Chief Medical Officer as disclosed in the Form 8-K dated November 5, 2024.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted in connection with the Reporting Person's appointment as Chief Medical Officer as disclosed in the Form 8-K dated November 5, 2024.